Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term cell. Found 21 abstracts

no pagination
Matulonis UA, Sharma S, Ghamande S, Gordon MS, Del Prete SA, Ray-Coquard I, Kutarska E, Liu H, Fingert H, Zhou XF, Danaee H, Schilder RJ. Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Gynecologic Oncology. 2012 Oct;127(1):63-9.   PMCID: Not NIH Funded
Simhan J, Smaldone MC, Tsai KJ, Li TY, Reyes JM, Canter D, Kutikov A, Chen DY, Greenberg RE, Uzzo RG, Viterbo R. Perioperative Outcomes of Robotic and Open Partial Nephrectomy for Moderately and Highly Complex Renal Lesions. J Urol. 2012 Jun;187(6):2000-4.
Burger RA. Overview of anti-angiogenic agents in development for ovarian cancer. Gynecologic Oncology. 2011 Apr;121(1):230-8.   PMCID: not NIH funded
Foreman JE, Chang WC, Palkar PS, Zhu BK, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional Characterization of Peroxisome Proliferator-Activated Receptor-beta/delta Expression in Colon Cancer. Molecular Carcinogenesis. 2011 Nov;50(11):884-900.   PMCID: PMC3482838[Available on 2012/11/1]
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC. Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1086-113.   PMCID: not NIH funded
Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MA, Joniau S, Kirkali Z, Marberger M, Patard JJ, Staehler M, Uzzo RG. Contemporary Management of Small Renal Masses. European Urology. 2011 Sep;60(3):501-15.   PMCID: not NIH funded
Ratner E, Lu LG, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, Schwartz P, Santin A, Matloff E, Zelterman D, Slack FJ, Weidhaas JB. A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk. Cancer Research. 2010 Aug;70(16):6509-15.   PMCID: PMCID: PMC2923587 [Available on 2011/8/1]
Ronty M, Taivainen A, Moza M, Kruh GD, Ehler E, Carpen O. Involvement of palladin and alpha-actinin in targeting of the Abl/Arg kinase adaptor ArgBP2 to the actin cytoskeleton. Experimental Cell Research. 2005 Oct 15;310(1):88-98.
Purev E, Cai DW, Miller E, Swoboda R, Klein-Szanto A, Marincola FM, Mick R, Otvos L, Wunner W, Birebent B, Somasundaram R, Wikstrand CJ, Bigner D, DeMichele A, Acs G, Berlin JA, Herlyn D. Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R). Journal of Immunology. 2004 Nov 15;173(10):6472-80.
Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncology Research. 1999 Jan;11(4):169-78.
Hu YF, Lau KM, Ho SM, Russo J. Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. International Journal of Oncology. 1998 Jun;12(6):1225-8.
Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, Ura H, Klein-Szanto AJ, Kohgo Y. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 1998 Jul 15;83(2):267-75.
Guo JT, Pugh JC. Monoclonal antibodies to a 55-kilodalton protein present in duck liver inhibit infection of primary duck hepatocytes with duck hepatitis B virus. Journal of Virology. 1997 Jun;71(6):4829-31.
Knudson AG. Hereditary cancer: Two hits revisited. Journal of Cancer Research and Clinical Oncology. 1996 Mar;122(3):135-40.
Rosvold E. Chemoprevention of lung cancer. Current Problems in Cancer. 1996 Jul;20(4):266-71.
Barnabas N, Moraes R, Calaf G, Estrada S, Russo J. Role of P53 in Mcf-10f Cell Immortalization and Chemically- Induced Neoplastic Transformation. International Journal of Oncology. 1995 Dec;7(6):1289-96.
Bowtell RW, Peters A, Sharp JC, Mansfield P, Hsu EW, Aiken N, Horsman A, Blackband SJ. Nmr Microscopy of Single Neurons Using Spin-Echo and Line Narrowed 2dft Imaging. Magnetic Resonance in Medicine. 1995 Jun;33(6):790-4.
Hiramatsu R, Akagi K, Matsuoka M, Sakumi K, Nakamura H, Kingsbury L, David C, Hardy RR, Yamamura K, Sakano H. The 3' enhancer region determines the B/T specificity and pro-B pre-B specificity of immunoglobulin V-kappa-J(kappa) joining. Cell. 1995 Dec 29;83(7):1113-23.
Zhang SY, Caamano J, Cooper F, Guo X, Kleinszanto AJ. Immunohistochemistry of Cyclin D1 in Human Breast-Cancer. American journal of clinical pathology. 1994 Nov;102(5):695-8.
Hayakawa K, Carmack CE, Shinton SA, Hardy RR. Selection of Autoantibody Specificities in the Ly-1 B Subset. Annals of the New York Academy of Sciences. 1992 May 04;651:346-53.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term cell

cell expression carcinoma transformation mammary epithelial-cells overexpression cancer tumors family trial proliferation carcinogenesis lung-cancer nephrectomy kidney-robotics-complications-classification t-2 relaxation tyrosine kinase inhibitor mucosal ppar-delta molecular-cloning human-breast-cancer particles 1993 lisle l-archives of internal medicine-v153-p746 mice envelope protein nonsteroidal antiinflammatory drugs a kinase radio-frequency estrogen receptor control wild-type p53 differential lung carcinomas biology natural-history multiinstitutional analysis Partial egfrviii lobules rearrangement Ovarian cancer Aurora A kinase-MLN8237-Platinum-refractory-Platinum-resistant wilms tumor association vitamin-e reverse cholesterol chemical carcinogens constant region development K-ras prevention surgical genes chromosome 11q13 analysis complications Surveillance platinum-resistant colony-stimulating factor line triple angiokinase inhibitor masses heavy interstitial deletion breast-cancer daily thoracic radiotherapy intensity growth risk confers enhanced tumorigenicity beta- receptors ets oncogene genetic bile-duct ras mutations junctional sequences papillary hyperplasia cohort esophageal cancer apoptosis microscopy estrogen receptor-beta focused ultrasound cytotoxic t-lymphocytes codon-12 mutations gene girdle muscular-dystrophy sarcomeric protein carotene acromegalic patients active surveillance Renal tumour biopsy colorectal-cancer cisplatin plus neuroendocrine tumors ret protooncogene smokers calcium regulation forthcoming 7th edition small pathogenesis nuclear antigen phase-iii trial susceptibility Renal mass messenger-rna molecular ovarian-cancer human breast epithelial cell multicenter randomized-trial laparoscopic radical prostatectomy MCF-10F cancer patients NCCN Guidelines single cells breast tumors pegylated liposomal doxorubicin laparoscopic partial nephrectomy plasma-membranes normal contralateral kidney tumorigenicity fibroblast-growth-factor Ovarian cancer avian hepadnavirus human glioblastoma gel- NCCN Clinical Practice Guidelines Ki67 11 cyclin d1 glycoprotein estrogen-receptor-beta identification biliary-tract tumors positron-emission-tomography abl tyrosine kinase phase-ii trial clonogenicity colon-cancer quality-of-life ablation z-disc cycle invitro conformation polymorphism carcinogens electrophoresis mutant p53 human tumor-antigens breast cancer vaccine development
Last updated on Wednesday, February 05, 2020